NDC 55150-329 – Medroxyprogesterone Acetate

Medroxyprogesterone Acetate 150 mg/mL · Injection, Suspension · Intramuscular

Human Prescription Drug 1 recall

Product NDC55150-329

Product details

Brand name
Medroxyprogesterone Acetate
Generic name
Medroxyprogesterone Acetate
Labeler
Eugia US LLC
Dosage form
Injection, Suspension
Route
Intramuscular
Marketing category
ANDA · ANDA212824
Marketed since
August 22, 2022
Listing expires
December 31, 2027
Pharmacologic class
Progestin

Active ingredients

Uses, dosage, side effects and warnings for Medroxyprogesterone acetate →

Package NDC codes (2)

Package NDCDescriptionSince
55150-329-011 VIAL, SINGLE-DOSE in 1 CARTON (55150-329-01) / 1 mL in 1 VIAL, SINGLE-DOSEAug 22, 2022
55150-329-2525 VIAL, SINGLE-DOSE in 1 CARTON (55150-329-25) / 1 mL in 1 VIAL, SINGLE-DOSEAug 22, 2022

Recalls mentioning this NDC

Other Medroxyprogesterone acetate products